Advancing a chemistry-driven approach to targeting the microbiome to treat disease & improve human health. Community Guidelines: https://t.co/Ef4RAU7eMT" title="" class="btn" data-container="body" data-html="true" data-id="44468" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Kaleido Biosciences"> 439 9,061
Activities
Entity types
Location
65 Hayden Ave, Lexington, MA 02421, USA
Lexington
United States of America
Employees
Scale: 51-200
Estimated: 11
Engaged corporates
3Added in Motherbase
5 years, 8 months agoWe are unyielding in our pursuit of life-changing therapies and our grit and compassion lead us to fight for a better future for patients and their families.
We believe there is tremendous potential in the area of targeting the immune system through the gut microbiome. By working with the microbiome rather than replacing it, Kaleido is in a unique position to unlock an untapped area of science with unprecedented new treatments.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 3 Apr 2019 | | |
![]() Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Not capitalistic Partnership Not event 7 Dec 2021 | | |
![]() Nasdaq Finance, Financial Services | Nasdaq Finance, Financial Services | Not capitalistic Partnership Event 28 Feb 2019 | |